DBV Technologies S.A. - ADR

$19.52

up-down-arrow $-0.32 (-1.61%)

As on 15-May-2026 10:37EDT

Market cap

info icon

$1,205 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.6

Div. Yield

info icon

0 %

DBV Technologies S.A. - ADR Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Stock Range

Today’s Range

Low: 19.51 High: 19.91

52 Week Range

Low: 7.53 High: 26.19

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.6 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -2.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-1.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    59,182,876

10 Years Aggregate

CFO

$-963.47 Mln

EBITDA

$-1,132.99 Mln

Net Profit

$-1,164.09 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
DBV Technologies S.A. - ADR
1.8 -9.8 -6.6 70.0 -0.5 -20.9 -23.6
BSE Sensex
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
DBV Technologies S.A. - ADR
520.4 -67.3 -37.7 -4.4 -38.9 -75.5 66.7
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

*All values are in ($ Mln)

*All values are in ($ Mln)

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
DBV Technologies S.A. - ADR
19.5 1,205.0 0.0 -167.9 -- -128.7 -- 5.6
813.3 50,825.9 5,779.3 1,830.5 8.7 27.3 36.1 6.6
106.9 10,398.1 6,066.4 609.2 18.3 16.7 17.9 4.2
21.7 11,687.9 19,358.7 944.6 9.0 5.5 11.3 0.8
27.5 1,862.3 1,043.8 488.8 -19.0 16 3.2 0.5
0.3 12.2 0.0 -9.7 -5,195.6 -- -- 227.7
13.0 891.5 106,763.2 5,307.0 5.8 2147 66.4 3.4
3.0 585.2 3.2 -198.4 -4,800.7 -166.3 -- 7.6
6.5 338.7 0.8 -75.0 -6,681.4 -- -- 6.7
20.7 2,201.0 453.3 -178.1 -27.8 -25.1 -- 3.2

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About DBV Technologies S.A. - ADR

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed...  Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France. Address: Bâtiment IRO, Châtillon, France, 92320  Read more

Edit peer-selector-edit

FAQs for DBV Technologies S.A. - ADR

The share price of DBV Technologies SA - ADR is $19.52 (NASDAQ) as of 15-May-2026 10:37 EDT. DBV Technologies SA - ADR has given a return of -0.47% in the last 3 years.

Since, TTM earnings of DBV Technologies SA - ADR is negative, P/E ratio is not available.
The P/B ratio of DBV Technologies SA - ADR is 5.62 times as on 12-May-2026, a 9 premium to its peers’ median range of 5.14 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-9.99
8.70
2024
-0.52
2.17
2023
-1.26
0.65
2022
-1.49
0.74
2021
-0.90
0.89

The 52-week high and low of DBV Technologies SA - ADR are Rs 26.19 and Rs 7.53 as of 15-May-2026.

DBV Technologies SA - ADR has a market capitalisation of $ 1,205 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in DBV Technologies SA - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.